Literature DB >> 17526185

[Progress in therapeutic principles and the characteristics of strategies for treatment of hypertension and its changes in China].

Chuh-song Hu1, Da-yi Hu.   

Abstract

To briefly introduce the updated principles for treatment of hypertension by reviewing foreign literatures in point of this aspect and its progress. The strategies of hypertension treatment in our country experienced the development from "non-principles (NP)", "partial principles (PP)" to "full principles (FP)", and already realized five conversions, i.e. the conversion from simply depress the blood pressure to multi-drugs, multi-targets and multi-pathways comprehensive therapy, and put stress on both prevention and treatment. The authors emphasized that NP should be rejected completely, and population proportion of PP, especially FP used should be elevated in hypertension treatment in the future.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17526185

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  4 in total

1.  A novel management program for hypertension.

Authors:  Chun-Song Hu; Ya-Ling Han; Jun-Bo Ge; Qing-Hua Wu; Yan-Na Liu; Chang-Sheng Ma; Tengiz Tkebuchava; Da-Yi Hu
Journal:  Cardiovasc Diagn Ther       Date:  2015-08

2.  Clinical study of western medicine combined with Chinese medicine based on syndrome differentiation in the patients with polarized hypertension.

Authors:  Song-lin Chen; Xiao-yun Liu; Wen-ming Xu; Wei-yi Mei; Xiao-lian Chen
Journal:  Chin J Integr Med       Date:  2012-09-11       Impact factor: 1.978

Review 3.  Cardiovascular, diabetes, and cancer strips: evidences, mechanisms, and classifications.

Authors:  Chun-Song Hu; Qing-Hua Wu; Da-Yi Hu
Journal:  J Thorac Dis       Date:  2014-09       Impact factor: 2.895

Review 4.  Novel strategies halt cardiovascular, diabetes, and cancer strips.

Authors:  Chun-Song Hu; Qing-Hua Wu; Da-Yi Hu; Tengiz Tkebuchava
Journal:  Chronic Dis Transl Med       Date:  2017-07-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.